Papapoulos, S.E., Quandt, S.A., Liberman, U.A., Hochberg, M.C. and Thompson, D.E. (2005) Meta-Analysis of the Efficacy of Alendronate for the Prevention of Hip Fractures in Postmenopausal Women. Osteoporosis International, 16, 468-474.
https://doi.org/10.1007/s00198-004-1725-z

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.